1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Liquid Biopsy Market- Key Findings, 2020

3. Strategic Imperatives on Global Liquid Biopsy Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Liquid Biopsy Companies

4.Liquid Biopsy Market Value Outlook to 2026 Outlook By Circulating Biomarker

• 4.1 Extracellular Vesicles (Evs)
• 4.2 Circulating Tumor Cells
• 4.3 Circulating Tumor DNA (CTDNA)
• 4.4 Cell-Free DNA
• 4.5 Other Circulating Biomarkers

5. Liquid Biopsy Market Value Outlook to 2026 Outlook By Product and Service

• 5.1 Instruments
• 5.2 Assay Kits
• 5.3 Services

6. Liquid Biopsy Market Value Outlook to 2026 Outlook By Application

• 6.1 Non-Cancer Applications
• 6.2 Cancer Applications
  • 6.2.1 Lung Cancer
  • 6.2.2 Liver Cancer
  • 6.2.3 Breast Cancer
  • 6.2.4 Prostate Cancer
  • 6.2.5 Colorectal Cancer
  • 6.2.6 Other Cancers

7. Liquid Biopsy Market Value Outlook to 2026 Outlook By Clinical Application

• 7.1 Treatment Monitoring
• 7.2 Recurrence Monitoring
• 7.3 Early Cancer Screening
• 7.4 Therapy Selection

8. Liquid Biopsy Market Value Outlook to 2026 Outlook By Technology

• 8.1 Multi-gene-parallel Analysis (NGS)
• 8.2 Single Gene Analysis (PCR Microarrays)

9. Liquid Biopsy Market Value Outlook to 2026 Outlook By End User

• 9.1 Hospitals and Physician Laboratories
• 9.2 Academic and Research Centers
• 9.3 Reference Laboratories
• 9.4 Other End Users

10 Asia Pacific Liquid Biopsy Market Value Outlook to 2026

• 10.1 Leading Liquid Biopsy Types contributing to Asia Pacific market
• 10.2 Top Applications contributing to Asia Pacific Liquid Biopsy
• 10.3 Top countries contributing to Asia Pacific Liquid Biopsy

11 Europe Liquid Biopsy Market Value Outlook to 2026

• 11.1 Leading Liquid Biopsy Types contributing to Europe market
• 11.2 Top Applications contributing to Europe Liquid Biopsy
• 11.3 Top countries contributing to Europe Liquid Biopsy

12 North America Liquid Biopsy Market Value Outlook to 2026

• 12.1 Leading Liquid Biopsy Types contributing to North America market
• 12.2 Top Applications contributing to North America Liquid Biopsy
• 12.3 Top countries contributing to North America Liquid Biopsy

13 South and Central America Liquid Biopsy Market Value Outlook to 2026

• 13.1 Leading Liquid Biopsy Types contributing to South and Central America market
• 13.2 Top Applications contributing to South and Central America Liquid Biopsy
• 13.3 Top countries contributing to South and Central America Liquid Biopsy

14 Middle East Africa Liquid Biopsy Market Value Outlook to 2026

• 14.1 Leading Liquid Biopsy Types contributing to Middle East Africa market
• 14.2 Top Applications contributing to Middle East Africa Liquid Biopsy
• 14.3 Top countries contributing to Middle East Africa Liquid Biopsy

15 Business Profiles of Leading Companies

• 15.1 Business Description, SWOT and Financial Analysis of Companies in Liquid Biopsy market
• 15.2 Bio-Rad Laboratories, Inc.
• 15.3 Biocept, Inc.
• 15.4 Genomic Health, Inc.
• 15.5 Menarini-Silicon Biosystems
• 15.6 Myriad Genetics, Inc
• 15.7 Qiagen N.V.
• 15.8 Raindance Technologies, Inc
• 15.9 Roche Diagnostics
• 15.10 Thermo Fisher Scientific Inc.
• 15.11 Trovagene, Inc.

16 Recent Industry Developments

17 Appendix

• 17.1 OGAnalysis Expertise
• 17.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the Liquid Biopsy market including the COVID-19 pandemic implications for Liquid Biopsys industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Liquid Biopsy market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Liquid Biopsy Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Liquid Biopsy market forecast and Liquid Biopsy market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Liquid Biopsy market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Liquid Biopsy industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Liquid Biopsy market share in developed countries.

Scope of the research-

Liquid Biopsy Market Value Outlook to 202 Outlook By Circulating Biomarker
Extracellular Vesicles (Evs) 
Circulating Tumor Cells
Circulating Tumor DNA (CTDNA) 
Cell-Free DNA 
Other Circulating Biomarkers

Liquid Biopsy Market is analyzed and forecast over the outlook period from 2020 to 2026 By Product including and Service
Instruments
Assay Kits
Services

Liquid Biopsy Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Non-Cancer Applications
Cancer Applications
Lung Cancer
Liver Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other Cancers

Liquid Biopsy Market Value Outlook to 202 Outlook By Clinical Application
Treatment Monitoring 
Recurrence Monitoring
Early Cancer Screening 
Therapy Selection 

Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2020 to 2026 by technology including
Multi-gene-parallel Analysis (NGS)
Single Gene Analysis (PCR Microarrays)

Liquid Biopsy Market Value Outlook to 202 Outlook Market is analyzed and forecast over the outlook period from 2020 to 2026 by End User including
Hospitals and Physician Laboratories
Academic and Research Centers
Reference Laboratories
Other End Users

Top Companies Operating in Liquid Biopsy market include- Bio-Rad Laboratories, Inc.  , Biocept, Inc.  , Genomic Health, Inc.  , Menarini-Silicon Biosystems  , Myriad Genetics, Inc  , Qiagen N.V.  , Raindance Technologies, Inc  , Roche Diagnostics  , 150 Thermo Fisher Scientific Inc. , 151 Trovagene, Inc.  ,
Recent Industry Developments

1Appendix
1OGAnalysis Expertise
1Sources and Methodology
1Contacts